Results

Total Results: 199 records

Showing results for "end stage renal".

101. Physiologic Predictors of the Need for Trauma Center Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
     May 31, 2017 - several additional factors such as age, prior conditions (e.g., anticoagulation and bleeding disorders, end-stage … renal disease, pregnancy>20 weeks), burns with or without trauma, and EMS judgement and recommends … such as complexity/variability of heart rate, tissue O2 saturation, mean arterial pressure, lactate, end-tidal … limited to respiration rate, tissue O2 saturation, respiratory effort, measure of acidemia (e.g., end-tidal … The end points or “outcomes” of interest are the predictive utility of the measures.

102. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) o Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

103. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
     December 20, 2011 - and the potential influences of confounders such as age, ethnicity, and comorbidities (including renal … has been used to include or exclude subjects (e.g., acute coronary syndrome (ACS), CAD, Diabetes, Renal … widened QRS interval on 12-lead electrocardiogram, chronic hypotension, resting tachycardia, and renal … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end- users, individuals are invited to serve as Key Informants and those who

104. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - were no clear differences between fluorescent cystoscopy and white light cystoscopy in the risk of renal … tumor stage. … Fluorescent vs. white light cystoscopy: renal and genitourinary adverse events Low There were no … clear differences between fluorescent cystoscopy and white light cystoscopy in risk of renal and genitourinary … Surveillance, Epidemiology and End Results Program: Turning Cancer Data Into Discovery.

105. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - 2013, this criterion includes at least five of nine core chronic conditions—Alzheimer’s disease and end-stage … renal disease were the added conditions. … Because of the stage of the science in this area, we anticipate that the benefit from conducting a systematic … pressure; total, low-density lipoprotein, or high-density lipoprotein cholesterol; pulmonary function; renal … Because of their role as end-users, individuals are invited to serve as Key Informants, and those who

106. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … Serum free light chain measurements move to center stage. … Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high … Failure Due to Myeloma Cast Nephropathy Recruiting Chronic renal failure with uremic nephropathy

107. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - Major—renal toxicity, hepatic toxicity, gastrointestinal upset c. … Source: www.effectivehealthcare.ahrq.gov Published Online: September 13, 2012 Key Informants are the end-users … Because of their role as end-users, individuals are invited to serve as Key Informants and those who … multiple daily doses Aminoglycosides Gentamicin, tobramycin, amikacin Can be dosed once daily Major renal … toxicity; requires close monitoring of dose, drug levels, renal function Abbreviations: C. diff

108. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
     May 29, 2025 - Effects"on"office"and"home"blood"pressure" of"the"lercanidipine'enalapril"combination"in"patients"with"Stage … Blood"pressure"changes"after"renal"denervation"at"10"European"expert" centers." … Abstracts"from"relevant"literature"are"included"at"the"end"of"the"attached" document." … $Abstracts$are$provided$for$included$literature$at$the$end$of$ the$document.$ Conclusions(From(Original … Usual(Care:( Clinical(Outcomes( SOE:(Insufficient( ( One$quality$C$study$reported$ on$mortality$and$end"stage

109. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with renal failure Interventions … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage

110. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Excluded: Pregnant women, HIV co-infected, transplant recipients, patients with renal failure Interventions … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … No trials reported harms in patients stratified by factors such as HCV genotype, age, race, sex, stage … response; RR = relative risk; HCV-RNA = hepatitis c virus-ribonucleic acid; BMI = body mass index; ESLD = end-stage

111. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
     November 27, 2012 - With such a large population progressing toward end-stage liver disease we need to find these people … needlessly suffer and our healthcare system will be further overburdened and, frankly, overrun, with end-stage … screening becomes irrelevant because a substantial proportion of HCV patients will have developed end-stage … Stage Renal Disease. … I have seen many many hospitalized patients with end stage liver disease who are alcoholics AND have

112. Hepatitis-C Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
     November 01, 2012 - refers to the cross-linking of polyethylene glycol molecules to the interferon molecule, which delays renal … harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … performed in groups stratified by HCV genotype as well as by race, age, body weight, viral load, stage … improvement in measures related to quality of life (generic or disease-specific) 24 weeks after the end … Low bid = twice daily; CI = confidence interval; ESLD = end-stage liver disease; HCC = hepatocellular

113. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - refers to the cross-linking of polyethylene glycol molecules to the interferon molecule, which delays renal … improvement in measures related to quality of life (generic or disease-specific) 24 weeks after the end … Low Note: CI=confidence interval, ESLD=end-stage liver disease, HCC=hepatocellular carcinoma, HCV=hepatitis … week 8 Alanine aminotransferase and aspartate aminotransferase normalization: in normal range at end … in relation to Interleukin 28B (IL28-b) expression Incidence of anemia Response rate (rapid/early/end

114. Machine Learning Methods in Systematic Reviews: Identifying Quality Improvement Intervention Evaluations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
     September 01, 2012 - While adherence improved, many patients still failed to receive 100% indicated treatments at the end … Health care institutions struggle with the challenge of providing excellent palliative and end-of-life … BACKGROUND: High quality end-of-life care in the community is achieved with effective multidisciplinary … BACKGROUND: Chronic renal failure and haemodialysis treatment is a long-term process; patients need … become established in partnership working; the collaborative approach to providing palliative care for end-stage

115. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
     May 04, 2017 - Many tools are designed for e.g., oncology, renal, or other populations. … How did the tools align to stage of a condition/illness and symptoms? … care” for each tool (in the appendices) but this often did not include stage or symptoms. 22 Peer … Measuring the quality of end-of-life care. … We did not focus on end of life care and hospice.

116. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
     May 04, 2017 - Many tools are designed for e.g., oncology, renal, or other populations. … How did the tools align to stage of a condition/illness and symptoms? … care” for each tool (in the appendices) but this often did not include stage or symptoms. 22 Peer … Measuring the quality of end-of-life care. … We did not focus on end of life care and hospice.

117. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - include the microvascular complications of retinopathy and blindness, neuropathy, nephropathy, and end-stage … pressure and heart rate, and for studies that include a comparison with SGLT-2 inhibitors, impaired renal … The exclusion criteria were generally similar for most trials: significant renal, cardiovasular, and … rosiglitazone and pioglitazone, are contraindicated in patients with serious or severe heart failure (Stage … 3 or Stage 4) according to product labels.54, 55 We had low or insufficient strength of evidence for

118. Ch 8-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
     October 01, 2013 - unscheduled pill-count visits over the six- month study period while viral suppression was determined at the end … As an example, the United States Renal Data System (USRDS) is a registry of individuals receiving dialysis … patients (6-9% incomplete in early-stage patients versus 13-23% incomplete in late-stage patients).9 … I or Stage III hypertension? … In the end, the validity of the study is only as good as the quality of the data. 124 Developing

119. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
     April 25, 2013 - We also refer Figure 1 at the end of this document and comments accompanying the Figure on later (Page … Methods Page 13, Line 22: It might be more technically correct to say "...published subsequent to the end … For example, baseline Hb was explored but not Added comment on comparison to end of Results paragraph … Fig 13 and to label for the horizontal axis Page 72, line 10: A brief summary paragraph at the end … those with the worse prognosis have the greatest harms, which is in some ways consistent with the renal

120. Hepatitis-C-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
     November 01, 2012 - long lag time between infection and development of cirrhosis and other complications.2 HCV-related end-stage … other patients, inflammation and fibrosis of the liver may progress to cirrhosis, which can lead to end-stage … For example, patients with end-stage liver disease or undergoing biopsy for hepatocellular carcinoma … Our findings are not applicable to patients with HIV infection, end-stage renal disease, or following … Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a